The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

Key Points

• Cellular-based immunotherapy shows promise in enhancing immune responses against gastric cancer.
• Recent clinical trials indicate significant engagement with the tumor microenvironment, boosting treatment efficacy.
• Analysis of multiple trials highlights various interventions and their impacts on patient outcomes.
• The growing body of evidence supports further exploration into cellular-based immunotherapies for broader applications.